| 1 |
Chen FF, Yu XJ, Wang H, Zhang X, Tan Y, Qu Z, Wang SX, Yu F, Chen M, Zhao MH. Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy. Ren Fail 2023;45:2161396. [PMID: 36648027 DOI: 10.1080/0886022X.2022.2161396] [Reference Citation Analysis]
|
| 2 |
Galvez C, Krall P, Rojas A, Oh J, Cano F. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl. Pediatr Nephrol 2023;38:1195-203. [PMID: 35969277 DOI: 10.1007/s00467-022-05694-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Moore M, Afolayan-Oloye O, Kroneman O, Li W, Kanaan HD, Zhang PL. Proteinuria in thrombotic microangiopathy is associated with partial podocytopathy. Ultrastruct Pathol 2023;:1-8. [PMID: 36906888 DOI: 10.1080/01913123.2023.2189341] [Reference Citation Analysis]
|
| 4 |
Ravindran A, Pereira Palma LM, Fervenza FC, Sethi S. Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series. Kidney Int Rep 2023;8:619-27. [PMID: 36938079 DOI: 10.1016/j.ekir.2022.12.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Porubsky S. [Electron microscopy in nephropathology]. Pathologie (Heidelb) 2023;44:84-94. [PMID: 36480038 DOI: 10.1007/s00292-022-01164-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Komisarof J, Forman J, Goldman B, Syposs C, Passero F, Garbade E. A Rare Case of Renal Thrombotic Microangiopathy and Focal Segmental Glomerulosclerosis Secondary to Plasma Cell Leukemia. Case Rep Hematol 2023;2023:7803704. [PMID: 36852298 DOI: 10.1155/2023/7803704] [Reference Citation Analysis]
|
| 7 |
Teoh CW, Riedl Khursigara M, Ortiz-Sandoval CG, Park JW, Li J, Bohorquez-Hernandez A, Bruno V, Bowen EE, Freeman SA, Robinson LA, Licht C. The loss of glycocalyx integrity impairs complement factor H binding and contributes to cyclosporine-induced endothelial cell injury. Front Med (Lausanne) 2023;10:891513. [PMID: 36860338 DOI: 10.3389/fmed.2023.891513] [Reference Citation Analysis]
|
| 8 |
González DET, Misol DD, Ordoñez NA, Zamora FAS, Millan Prada HA, Zuñiga R E, Triviño AM. Atypical hemolytic uremic syndrome in a patient with HIV treated with eculizumab: A case report. IDCases 2023;31:e01692. [PMID: 36699966 DOI: 10.1016/j.idcr.2023.e01692] [Reference Citation Analysis]
|
| 9 |
Yamano Y, Minakata T, Tsuji T, Hayashi S, Hashimoto S. A Case of Recurrent Ovarian Cancer with Renal Dysfunction Associated with the Use of Olaparib. SN Compr Clin Med 2023;5:51. [DOI: 10.1007/s42399-023-01390-7] [Reference Citation Analysis]
|
| 10 |
Mazzierli T, Allegretta F, Maffini E, Allinovi M. Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management. Front Pharmacol 2022;13:1088031. [PMID: 36699080 DOI: 10.3389/fphar.2022.1088031] [Reference Citation Analysis]
|
| 11 |
Gunji M, Sawa C, Akiyama M, Mukai S, Takaki T, Kang D, Honda K. Gemcitabine alters sialic acid binding of the glycocalyx and induces inflammatory cytokine production in cultured endothelial cells. Med Mol Morphol 2023;:1-10. [PMID: 36622466 DOI: 10.1007/s00795-022-00347-4] [Reference Citation Analysis]
|
| 12 |
Smith-Jackson K, Harrison RA. Alternative pathway activation in pregnancy, a measured amount "complements" a successful pregnancy, too much results in adverse events. Immunol Rev 2023;313:298-319. [PMID: 36377667 DOI: 10.1111/imr.13169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Albrecht S, Kamla CE, Schönermarck U, Wassilowsky D. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome]. Anaesthesiologie 2023;72:3-12. [PMID: 36454255 DOI: 10.1007/s00101-022-01221-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Taner S, Karaçay IET, Arslan İ. Acute pancreatitis complicated by hemolytic uremic syndrome: a pediatric case. Egypt Pediatric Association Gaz 2022;70:43. [DOI: 10.1186/s43054-022-00140-z] [Reference Citation Analysis]
|
| 15 |
Hallam TM, Cox TE, Smith-Jackson K, Brocklebank V, Baral AJ, Tzoumas N, Steel DH, Wong EKS, Shuttleworth VG, Lotery AJ, Harris CL, Marchbank KJ, Kavanagh D. A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration. Front Immunol 2022;13:1028760. [PMID: 36643920 DOI: 10.3389/fimmu.2022.1028760] [Reference Citation Analysis]
|
| 16 |
Zhang B, Xing G. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation. Front Immunol 2022;13:1081942. [PMID: 36582241 DOI: 10.3389/fimmu.2022.1081942] [Reference Citation Analysis]
|
| 17 |
Van den Eeckhaut L, Hannon H, Schurgers M, Monsaert E, Claes K. Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report. J Gastrointest Oncol 2022;13:3314-20. [PMID: 36636054 DOI: 10.21037/jgo-22-509] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Chen YY, Sun X, Huang W, He FF, Zhang C. Therapeutic apheresis in kidney diseases: an updated review. Ren Fail 2022;44:842-57. [PMID: 35723077 DOI: 10.1080/0886022X.2022.2073892] [Reference Citation Analysis]
|
| 19 |
Kolb T, Rump LC. De-novo-thrombotische Mikroangiopathie (TMA) nach inkompatibler AB0-Nierentransplantation. Transfusionsmedizin 2022;12:223-226. [DOI: 10.1055/a-1941-9839] [Reference Citation Analysis]
|
| 20 |
Glover EK, Smith-Jackson K, Brocklebank V, Wilson V, Walsh PR, Montgomery EK, Wong EKS, Johnson S, Malina M, Kavanagh D, Sheerin NS; UK aHUS Transplant Consortium, UK aHUS Transplant Consortium. Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome. Transplantation 2022. [PMID: 36413152 DOI: 10.1097/TP.0000000000004355] [Reference Citation Analysis]
|
| 21 |
Rivera FB, Ansay MFM, Golbin JM, Alfonso PGI, Mangubat GFE, Menghrajani RHS, Placino S, Taliño MKV, De Luna DV, Cabrera N, Trinidad CN, Kazory A. HIV-Associated Nephropathy in 2022. Glomerular Dis 2023;3:1-11. [PMID: 36816427 DOI: 10.1159/000526868] [Reference Citation Analysis]
|
| 22 |
Gaál Kovalčíková A, Janovičová Ľ, Hodosy J, Bábíčková J, Vavrincová-Yaghi D, Vavrinec P, Boor P, Podracká Ľ, Šebeková K, Celec P, Tóthová Ľ. Extracellular DNA concentrations in various aetiologies of acute kidney injury. Sci Rep 2022;12:16812. [PMID: 36207374 DOI: 10.1038/s41598-022-21248-7] [Reference Citation Analysis]
|
| 23 |
Kaimori R, Nishida H, Uchida T, Tamura M, Kuroki K, Murata K, Hatakeyama K, Ikeda Y, Amemiya K, Nishizono A, Daa T, Mori S. Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report. Thromb J 2022;20:61. [PMID: 36203145 DOI: 10.1186/s12959-022-00418-7] [Reference Citation Analysis]
|
| 24 |
Malgaj Vrečko M, Aleš Rigler A, Večerić-haler Ž. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review. IJMS 2022;23:11307. [DOI: 10.3390/ijms231911307] [Reference Citation Analysis]
|
| 25 |
Smith CJ, Ross N, Kamal A, Kim KY, Kropf E, Deschatelets P, Francois C, Quinn WJ, Singh I, Majowicz A, Mingozzi F, Kuranda K. Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood. Front Immunol 2022;13:999021. [DOI: 10.3389/fimmu.2022.999021] [Reference Citation Analysis]
|
| 26 |
Petr V, Csuka D, Hruba P, Szilágyi Á, Kollar M, Slavcev A, Prohászka Z, Viklicky O. MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy. Front Immunol 2022;13:985766. [DOI: 10.3389/fimmu.2022.985766] [Reference Citation Analysis]
|
| 27 |
Alghobaishi A, Mousa AH, Alshaltoni RS, Mohsen AS, Baothman A, Adem H, Eisa Y, Amin A, Edrees B. Two concomitant thrombotic microangiopathies in the background of systemic lupus erythematosus: A case report. Annals of Medicine and Surgery 2022;81:104541. [DOI: 10.1016/j.amsu.2022.104541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 28 |
Thompson GL, Kavanagh D. Diagnosis and treatment of thrombotic microangiopathy. Int J Lab Hematol 2022;44 Suppl 1:101-13. [PMID: 36074708 DOI: 10.1111/ijlh.13954] [Reference Citation Analysis]
|
| 29 |
Yamano Y, Minakata T, Tsuji T, Hayashi S, Hashimoto S. A case of recurrent ovarian cancer with renal dysfunction associated with the use of olaparib.. [DOI: 10.21203/rs.3.rs-1680826/v1] [Reference Citation Analysis]
|
| 30 |
Garcia de Herreros M, Esposito F, Sauri T, Font C. Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. J Oncol Pharm Pract 2022;:10781552221114653. [PMID: 35876362 DOI: 10.1177/10781552221114653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Kovala M, Seppälä M, Kaartinen K, Meri S, Honkanen E, Räisänen-Sokolowski A. Vascular Occlusion in Kidney Biopsy Is Characteristic of Clinically Manifesting Thrombotic Microangiopathy. J Clin Med 2022;11:3124. [PMID: 35683519 DOI: 10.3390/jcm11113124] [Reference Citation Analysis]
|
| 32 |
Kircheis R, Planz O. Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? Int J Mol Sci 2022;23:5966. [PMID: 35682644 DOI: 10.3390/ijms23115966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 33 |
Font C, de Herreros MG, Tsoukalas N, Brito-Dellan N, Espósito F, Escalante C, Oo TH; MASCC Hemostasis Study Group. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Support Care Cancer 2022. [PMID: 35545722 DOI: 10.1007/s00520-022-06935-5] [Reference Citation Analysis]
|
| 34 |
Allard J, Bonnet M, Laurent L, Bouattour M, Gagaille MP, Leclerc V. Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review. Eur J Clin Pharmacol 2022. [PMID: 35507073 DOI: 10.1007/s00228-022-03324-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Riedl Khursigara M, Matsuda-Abedini M, Radhakrishnan S, Hladunewich MA, Lemaire M, Teoh CW, Noone D, Licht C. A Guide for Adult Nephrologists and Hematologists to Managing Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy in Teens Transitioning to Young Adults. Adv Chronic Kidney Dis 2022;29:231-42. [PMID: 36084970 DOI: 10.1053/j.ackd.2022.04.003] [Reference Citation Analysis]
|
| 36 |
Büttner-herold M, Gaspert A, Amann K. Grundlagen der Nierenpathologie für Pathologen – Teil 1. Pathologe 2022;43:231-246. [DOI: 10.1007/s00292-022-01061-9] [Reference Citation Analysis]
|
| 37 |
Abou‐ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S. Thrombotic microangiopathies: An illustrated review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12708] [Reference Citation Analysis]
|
| 38 |
Emirova KM, Abaseeva TY, Baranov AA, Vashakmadze ND, Vishneva EA, Generalova GA, Zakharova EY, Kaluzhnaya TA, Kutsev SI, Namazova-baranova LS, Makarova TP, Margieva TV, Mstislavskaya SA, Muzurov AL, Pankratenko TE, Shilova MM, Fedoseenko MV. Modern Approaches to the Management of Children with Atypical Hemolytic Uremic Syndrome. Pediatr farmakol 2022;19:127-152. [DOI: 10.15690/pf.v19i2.2400] [Reference Citation Analysis]
|
| 39 |
Najar H, Tuider L, Kukkar V, Quasem M. Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury. Cureus. [DOI: 10.7759/cureus.24221] [Reference Citation Analysis]
|
| 40 |
Horino T, Inotani S, Ishihara M, Terada Y. Gemcitabine‐induced renal thrombotic microangiopathy. Nephrology. [DOI: 10.1111/nep.14043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Formeck CL, Manrique-caballero CL, Gómez H, Kellum JA. Uncommon Causes of Acute Kidney Injury. Critical Care Clinics 2022;38:317-47. [DOI: 10.1016/j.ccc.2021.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Chen X, Wang Y, Yu X, Wang S, Zhao M. Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis. Front Med 2022;9:836155. [DOI: 10.3389/fmed.2022.836155] [Reference Citation Analysis]
|
| 43 |
Scurt FG, Morgenroth R, Bose K, Mertens PR, Chatzikyrkou C. Pr-AKI: Acute Kidney Injury in Pregnancy – Etiology, Diagnostic Workup, Management. Geburtshilfe Frauenheilkd 2022;82:297-316. [DOI: 10.1055/a-1666-0483] [Reference Citation Analysis]
|
| 44 |
Devarajan P, Chertow GM, Susztak K, Levin A, Agarwal R, Stenvinkel P, Chapman AB, Warady BA. Emerging Role of Clinical Genetics in CKD. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100435] [Reference Citation Analysis]
|
| 45 |
Nasrollahi F, Eilbert W. Thrombotic microangiopathy presenting with stroke-like symptoms. Am J Emerg Med 2022:S0735-6757(22)00035-3. [PMID: 35094883 DOI: 10.1016/j.ajem.2022.01.032] [Reference Citation Analysis]
|
| 46 |
Halimi J, Thoreau B, von Tokarski F, Bauvois A, Gueguen J, Goin N, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Lemaignen A, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Frémeaux-bacchi V, Vigneau C, Bayer G, Fakhouri F. What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02672-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Baiko SV, Strelchenia ES, Reut SU. Hemolytic uremic syndrome associated with <i>Streptococcus pneumoniae</i>. Ross vestn perinatol pediatr 2022;66:134-141. [DOI: 10.21508/1027-4065-2021-66-6-134-141] [Reference Citation Analysis]
|
| 48 |
Kong W, Wang Y, Wang H, Zhou Q, Chen J, Han F. Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review. BMC Nephrol 2022;23:22. [PMID: 35012481 DOI: 10.1186/s12882-021-02639-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Hakroush S, Wulf S, Gallwas J, Tampe B. Case Report: Collapsing Focal Segmental Glomerulosclerosis After Initiation of Ado-Trastuzumab Emtansine Therapy. Front Oncol 2021;11:796223. [PMID: 34912725 DOI: 10.3389/fonc.2021.796223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Filippone EJ, Newman ED, Li L, Gulati R, Farber JL. Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review. Front Immunol 2021;12:780107. [PMID: 34858436 DOI: 10.3389/fimmu.2021.780107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 51 |
Shawky S, Safouh H, Gamal M, Abbas MM, Aboul-Enein A, Sawai T, Fahmy Y, Selim H. Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome. Int J Nephrol 2021;2021:6904858. [PMID: 34840826 DOI: 10.1155/2021/6904858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Ormonde C, Querido S, Rombo N, Roque R, Clemente B, Weigert A. Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient. Case Rep Transplant 2021;2021:9261371. [PMID: 34820145 DOI: 10.1155/2021/9261371] [Reference Citation Analysis]
|
| 53 |
Sluhanchuk EV, Bitsadze VO, Khizroeva JK, Tretyakova MV, Shkoda AS, Artyukov OP, Tsibizova VI, Mishchenko AL, Grigorieva KN, Gris J, Elalamy E, Makatsariya AD. COVID-19 and thrombotic microangiopathy. Akušerstvo, ginekologiâ i reprodukciâ 2021;15:639-657. [DOI: 10.17749/2313-7347/ob.gyn.rep.2021.265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Iwafuchi Y, Morioka T, Oyama Y, Goto S, Narita I. Complement Factor H Gene Variant in a Patient with Thrombotic Microangiopathy on a Mixed Clinical Background. Case Rep Nephrol 2021;2021:2519918. [PMID: 34733563 DOI: 10.1155/2021/2519918] [Reference Citation Analysis]
|
| 55 |
Coelho Júnior JL, Israel KCP, Machado CEE, Muniz MPR, Gatto GC, Barros FHS, Cunha KA, de Lacerda MVG, Neves PDMM, Silva GEB. Thrombotic microangiopathy associated with arboviral infection: Report of 3 cases. PLoS Negl Trop Dis 2021;15:e0009790. [PMID: 34648498 DOI: 10.1371/journal.pntd.0009790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 56 |
Veríssimo R, Mateus C, Laranjinha I, Manso RT, Dickson J, Gonçalves M, Gaspar MA, Machado D. Thrombotic microangiopathy triggered by podocytopathy. Clin Nephrol Case Stud 2021;9:110-6. [PMID: 34646728 DOI: 10.5414/CNCS110534] [Reference Citation Analysis]
|
| 57 |
Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 58 |
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100:S1-S276. [PMID: 34556256 DOI: 10.1016/j.kint.2021.05.021] [Cited by in Crossref: 137] [Cited by in F6Publishing: 184] [Article Influence: 68.5] [Reference Citation Analysis]
|
| 59 |
Newton J, Floyd L, Ponnusamy A, Anderton J. Thrombotic microangiopathy secondary to recurrent prostate cancer. Clin Nephrol Case Stud 2021;9:105-9. [PMID: 34549020 DOI: 10.5414/CNCS110609] [Reference Citation Analysis]
|
| 60 |
Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 2021;106:2170-9. [PMID: 34011137 DOI: 10.3324/haematol.2021.279000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 61 |
Mccluskey G, Davies GE, Velounias RL, Hughes TR, Morgan BP, Preston RJS, Collins PW, Jenkins PV, Heurich M. Complement Regulator Factor H is a Cofactor for Thrombin in both Pro- and Anticoagulant Roles.. [DOI: 10.1101/2021.07.22.452893] [Reference Citation Analysis]
|
| 62 |
Pirasath S, Athirayan C, Gajan D. Thrombotic microangiopathy following saw-scaled viper (Echis carinatus) envenoming in Sri Lanka. SAGE Open Med Case Rep 2021;9:2050313X211032399. [PMID: 34345431 DOI: 10.1177/2050313X211032399] [Reference Citation Analysis]
|
| 63 |
Guzzo G, Kissling S, Pantaleo G, Pascual M, Sadallah S, Teta D. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report. BMC Nephrol 2021;22:252. [PMID: 34229609 DOI: 10.1186/s12882-021-02456-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 64 |
Grunenwald A, Roumenina LT. The Benefits of Complement Measurements for the Clinical Practice. Methods Mol Biol 2021;2227:1-20. [PMID: 33847926 DOI: 10.1007/978-1-0716-1016-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 65 |
Tu KH, Fan PY, Chen TD, Chuang WY, Wu CY, Ku CL, Tian YC, Yang CW, Fang JT, Yang HY. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities. Int J Mol Sci 2021;22:6286. [PMID: 34208103 DOI: 10.3390/ijms22126286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 66 |
Saibaba J, Selvaraj J, Viswanathan S, Pillai V, Srinivas BH, Mandal J. Diarrhea and Acute Tubular Necrosis Mimicking Hemolytic Uremic Syndrome in a Man With Immunoglobulin A (IgA) Nephropathy. Cureus 2021;13:e15369. [PMID: 34239797 DOI: 10.7759/cureus.15369] [Reference Citation Analysis]
|
| 67 |
Zhou C, Song C, Huang X, Chen S, Long Y, Zeng S, Yang H, Jiang M. Early Prediction Model of Gestational Hypertension by Multi-Biomarkers Before 20 Weeks Gestation. Diabetes Metab Syndr Obes 2021;14:2441-51. [PMID: 34103953 DOI: 10.2147/DMSO.S309725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Willows J, Brown M, Sheerin NS. The role of complement in kidney disease. Clin Med (Lond) 2020;20:156-60. [PMID: 32188650 DOI: 10.7861/clinmed.2019-0452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 69 |
Nishikubo M, Shimomura Y, Hiramoto N, Sawamura N, Yamaguchi T, Hara S, Ishikawa T. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. BMC Nephrol 2021;22:175. [PMID: 33980166 DOI: 10.1186/s12882-021-02386-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Baiko SV. Epidemiology and pathophysiology of hemolytic uremic syndrome associated with shiga toxin (literature review). Nefrologiâ (St -Peterbg ) 2021;25:36-42. [DOI: 10.36485/1561-6274-2021-25-3-36-42] [Reference Citation Analysis]
|
| 71 |
McFarlane PA, Bitzan M, Broome C, Baran D, Garland J, Girard LP, Grewal K, Lapeyraque AL, Patriquin CJ, Pavenski K, Licht C. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review. Can J Kidney Health Dis 2021;8:20543581211008707. [PMID: 33996107 DOI: 10.1177/20543581211008707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 72 |
Zeng S, Han M, Jiang M, Liu F, Hu Y, Long Y, Zhu C, Zeng F, Gan Q, Ye W, Fu W, Yang H. Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin. Reprod Biol Endocrinol 2021;19:56. [PMID: 33874952 DOI: 10.1186/s12958-021-00742-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 73 |
Kolb T, Rump LC. [De novo thombotic microangiopathy (TMA) after incompatible AB0 renal transplantation]. Dtsch Med Wochenschr 2021;146:530-3. [PMID: 33853171 DOI: 10.1055/a-1380-1668] [Reference Citation Analysis]
|
| 74 |
Henao-piedrahita N. Microangiopatías trombóticas primarias: una revisión narrativa. Med Lab 2021;25:485-499. [DOI: 10.36384/01232576.432] [Reference Citation Analysis]
|
| 75 |
Van Wynsberghe M, Flejeo J, Sakhi H, Ollero M, Sahali D, Izzedine H, Henique C. Nephrotoxicity of Anti-Angiogenic Therapies. Diagnostics (Basel) 2021;11:640. [PMID: 33916159 DOI: 10.3390/diagnostics11040640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Bridoux F, Cockwell P, Glezerman I, Gutgarts V, Hogan JJ, Jhaveri KD, Joly F, Nasr SH, Sawinski D, Leung N. Kidney injury and disease in patients with haematological malignancies. Nat Rev Nephrol 2021;17:386-401. [PMID: 33785910 DOI: 10.1038/s41581-021-00405-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 77 |
Kalla S, Ellis RJ, Campbell SB, Doucet B, Isbel N, Tie B, Jegatheesan D. Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient. J Kidney Cancer VHL 2021;8:25-31. [PMID: 33850692 DOI: 10.15586/jkcvhl.v8i1.161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 78 |
Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. Front Med (Lausanne) 2020;7:582272. [PMID: 33738291 DOI: 10.3389/fmed.2020.582272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 79 |
Langlo KAR, Silva GJJ, Overrein TS, Adams V, Wisløff U, Dalen H, Rolim N, Hallan SI. Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model. Front Cardiovasc Med 2020;7:626699. [PMID: 33644125 DOI: 10.3389/fcvm.2020.626699] [Reference Citation Analysis]
|
| 80 |
Breville G, Zamberg I, Sadallah S, Stephan C, Ponte B, Seebach JD. Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies. Front Immunol 2020;11:604759. [PMID: 33643292 DOI: 10.3389/fimmu.2020.604759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Sandino-Pérez J, Gutiérrez E, Caravaca-Fontán F, Morales E, Aubert-Girbal L, Delgado-Lillo R, Praga M. Haemolytic uraemic syndrome associated with pancreatitis: report of four cases and review of the literature. Clin Kidney J 2021;14:1946-52. [PMID: 34345418 DOI: 10.1093/ckj/sfaa245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Rassner M, Baur R, Wäsch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. BMC Nephrol 2021;22:32. [PMID: 33461512 DOI: 10.1186/s12882-020-02226-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 83 |
Wong EKS, Hallam TM, Brocklebank V, Walsh PR, Smith-Jackson K, Shuttleworth VG, Cox TE, Anderson HE, Barlow PN, Marchbank KJ, Harris CL, Kavanagh D. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD. Front Immunol 2020;11:602284. [PMID: 33519811 DOI: 10.3389/fimmu.2020.602284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 84 |
Taylan C, Sutherland SM. Therapeutic Apheresis in Children. Pediatric Dialysis 2021. [DOI: 10.1007/978-3-030-66861-7_48] [Reference Citation Analysis]
|
| 85 |
Almaani SJ, Mejia-vilet J, Rovin BH. Kidney disease. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00011-7] [Reference Citation Analysis]
|
| 86 |
Al Romaili D, Licht C. Up-to-Date Systematic Approach to the Spectrum of Thrombotic Microangiopathy. Advances in Critical Care Pediatric Nephrology 2021. [DOI: 10.1007/978-981-33-4554-6_19] [Reference Citation Analysis]
|
| 87 |
Ali RM, Hassan BEE, Mahmoud NMY. Pregnancy-Associated Thrombotic Thrombocytopenic Purpura and Hemolytic-Uremic Syndrome. Obstetric Catastrophes 2021. [DOI: 10.1007/978-3-030-70034-8_8] [Reference Citation Analysis]
|
| 88 |
Varghese B, Rajagopalan A, Prasath A, Ammayappan S. An interesting case of neonatal atypical hemolytic–uremic syndrome. Asian J Pediatr Nephrol 2021;4:89. [DOI: 10.4103/ajpn.ajpn_31_21] [Reference Citation Analysis]
|
| 89 |
Hallam TM, Marchbank KJ, Harris CL, Osmond C, Shuttleworth VG, Griffiths H, Cree AJ, Kavanagh D, Lotery AJ. Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2020;61:18. [PMID: 32516404 DOI: 10.1167/iovs.61.6.18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 90 |
Pivovarova AI, Thongprayoon C, Hansrivijit P, Kaewput W, Qureshi F, Boonpheng B, Bathini T, Mao MA, Vallabhajosyula S, Cheungpasitporn W. Thrombotic Microangiopathy among Hospitalized Patients with Systemic Lupus Erythematosus in the United States. Diseases 2020;9:3. [DOI: 10.3390/diseases9010003] [Reference Citation Analysis]
|
| 91 |
Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 92 |
Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, Balamuth FB, Blatz AM, Chiotos K, Fitzgerald JC, Giglia TM, Gollomp K, Odom John AR, Jasen C, Leng T, Petrosa W, Vella LA, Witmer C, Sullivan KE, Laskin BL, Hensley SE, Bassiri H, Behrens EM, Teachey DT. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv 2020;4:6051-63. [PMID: 33290544 DOI: 10.1182/bloodadvances.2020003471] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 93 |
Noutsos T, Currie BJ, Lek RA, Isbister GK. Snakebite associated thrombotic microangiopathy: a systematic review of clinical features, outcomes, and evidence for interventions including plasmapheresis. PLoS Negl Trop Dis 2020;14:e0008936. [PMID: 33290400 DOI: 10.1371/journal.pntd.0008936] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 94 |
Tsiakas S, Skalioti C, Kotsi P, Boletis I, Marinaki S. Case of an unusual diagnosis of primary antiphospholipid syndrome with multiple clinical complications. Oxford Medical Case Reports 2020;2020. [DOI: 10.1093/omcr/omaa117] [Reference Citation Analysis]
|
| 95 |
Cosmai L, Porta C, Foramitti M, Perrone V, Mollica L, Gallieni M, Capasso G. Preventive strategies for acute kidney injury in cancer patients. Clin Kidney J 2021;14:70-83. [PMID: 33564407 DOI: 10.1093/ckj/sfaa127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 96 |
Hansrivijit P, Omeonu KF, Lawal HO, Gangireddy M, Gadhiya KP, Dhatt RS. A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma. Am J Case Rep 2020;21:e927030. [PMID: 33230093 DOI: 10.12659/AJCR.927030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 97 |
Mejia-Vilet JM, Gómez-Ruiz IA, Cruz C, Méndez-Pérez RA, Comunidad-Bonilla RA, Uribe-Uribe NO, Nuñez-Alvarez CA, Morales-Buenrostro LE. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis. Clin Rheumatol 2021;40:2233-42. [PMID: 33170371 DOI: 10.1007/s10067-020-05499-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 98 |
Blasco M, Guillén E, Quintana LF, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol JM, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. Clin Kidney J 2021;14:1055-66. [PMID: 33841853 DOI: 10.1093/ckj/sfaa195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 99 |
Neves PDMM, Souza RA, Torres FM, Reis FA, Pinheiro RB, Dias CB, Yu L, Woronik V, Furukawa LS, Cavalcante LB, de Almeida Araújo S, Wanderley DC, Malheiros DM, Jorge LB. Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy. PLoS One 2020;15:e0233199. [PMID: 33147224 DOI: 10.1371/journal.pone.0233199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 100 |
Kim MS, Lim SH, Kim JH, Ha I, Cheong HI, Kang HG. Rapid Resolution of Atypical Hemolytic Uremic Syndrome by Eculizumab Treatment. Child Kidney Dis 2020;24:138-142. [DOI: 10.3339/jkspn.2020.24.2.138] [Reference Citation Analysis]
|
| 101 |
Prasad C, Levy DM, Hebert D, Chami R, Teoh CW. An unusual etiology of thrombotic microangiopathy in an adolescent male: Answers. Pediatr Nephrol 2020;35:1857-64. [PMID: 32166357 DOI: 10.1007/s00467-020-04515-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 102 |
Sokova EA, Arkhipov VV, Mazerkina IA, Muslimova OV. Some Aspects of Drug Induced Nephrotoxicity Assessment. Bezopasnost' i risk farmakoterapii 2020;8:123-133. [DOI: 10.30895/2312-7821-2020-8-3-123-133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 103 |
Mota SMB, Albuquerque PLMM, Silva Júnior GBD, Daher EF. Thrombotic microangiopathy due to Bothrops erythromelas: a case report in Northeast Brazil. Rev Inst Med Trop Sao Paulo 2020;62:e53. [PMID: 32725056 DOI: 10.1590/s1678-9946202062053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Grechukhina KS, Chebotareva NV, Krasnova TN. Nephrotoxicity of anti-angiogenesis drugs. Terapevticheskii arkhiv 2020;92:93-98. [DOI: 10.26442/00403660.2020.06.000672] [Reference Citation Analysis]
|
| 105 |
Socha MW, Malinowski B, Puk O, Dubiel M, Wiciński M. The NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia. Cells 2020;9:E1642. [PMID: 32650532 DOI: 10.3390/cells9071642] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 106 |
Agarwal KA, Heher YK, Denker BM. Drug-Induced Thrombotic Microangiopathy Resulting in ESRD. Kidney Int Rep 2020;5:1350-5. [PMID: 32775839 DOI: 10.1016/j.ekir.2020.06.016] [Reference Citation Analysis]
|
| 107 |
Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 375] [Cited by in F6Publishing: 339] [Article Influence: 125.0] [Reference Citation Analysis]
|
| 108 |
Malekzadeh MM, Alizadeh R, Aghsaeifard Z, Sahraian MA. Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient. Clin Case Rep 2020;8:1061-4. [PMID: 32577265 DOI: 10.1002/ccr3.2808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
Park S, Lee YJ, Kim YW, Ko J, Park JH, Kim IH, Kim HJ, Oh D, Park BS. Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease. Am J Case Rep 2020;21:e922567. [PMID: 32361709 DOI: 10.12659/AJCR.922567] [Reference Citation Analysis]
|
| 110 |
Amann K, Daniel C, Büttner-herold M. Das Komplementsystem – ein „hot topic“ nicht nur bei Nierenerkrankungen. Pathologe 2020;41:238-247. [DOI: 10.1007/s00292-020-00773-0] [Reference Citation Analysis]
|
| 111 |
Neves PD, Souza RA, Torres FM, Reis FA, Pinheiro RB, Dias CB, Yu L, Woronik V, Furukawa LS, Cavalcante LB, Malheiros DM, Jorge LB. Evidences of histologic Thrombotic Microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.. [DOI: 10.1101/2020.05.01.072074] [Reference Citation Analysis]
|
| 112 |
Kaneda T, Tanaka E, Akutsu Y, Kanamori T, Mouri M, Morio T, Mori M. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient. CEN Case Rep 2020;9:301-7. [PMID: 32304042 DOI: 10.1007/s13730-020-00475-9] [Reference Citation Analysis]
|
| 113 |
Lokki AI, Haapio M, Heikkinen-Eloranta J. Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report. Front Immunol 2020;11:548. [PMID: 32308654 DOI: 10.3389/fimmu.2020.00548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 114 |
Aigner C, Gaggl M, Kain R, Prohászka Z, Garam N, Csuka D, Sunder-Plassmann R, Piggott LC, Haninger-Vacariu N, Schmidt A, Sunder-Plassmann G. Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy. J Clin Med 2020;9:E964. [PMID: 32244370 DOI: 10.3390/jcm9040964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 115 |
Brocklebank V, Kumar G, Howie AJ, Chandar J, Milford DV, Craze J, Evans J, Finlay E, Freundlich M, Gale DP, Inward C, Mraz M, Jones C, Wong W, Marks SD, Connolly J, Corner BM, Smith-Jackson K, Walsh PR, Marchbank KJ, Harris CL, Wilson V, Wong EKS, Malina M, Johnson S, Sheerin NS, Kavanagh D. Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy. Kidney Int 2020;97:1260-74. [PMID: 32386968 DOI: 10.1016/j.kint.2020.01.045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 116 |
Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS. Atypical hemolytic uremic syndrome: a case report. J Med Case Rep 2020;14:11. [PMID: 31928535 DOI: 10.1186/s13256-019-2334-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 117 |
Lee H, Kang E, Kang HG, Kim YH, Kim JS, Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, Cho H, Choi BS, Hong J, Cheong HI, Oh D. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020;35:25-40. [PMID: 31935318 DOI: 10.3904/kjim.2019.388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 118 |
Cohen SD, Kopp JB, Cathro H, Kimmel PL. Human Immunodeficiency Virus Infection and Chronic Kidney Disease. Chronic Renal Disease 2020. [DOI: 10.1016/b978-0-12-815876-0.00052-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 119 |
Barsoum RS, Wanas H, Shehab T. Anticoagulation in Patients with Renal Insufficiency. Precision Anticoagulation Medicine 2020. [DOI: 10.1007/978-3-030-25782-8_9] [Reference Citation Analysis]
|
| 120 |
Rayner HC, Thomas ME, Milford DV. Full Blood Count: Haematological Changes in Kidney Diseases. Understanding Kidney Diseases 2020. [DOI: 10.1007/978-3-030-43027-6_14] [Reference Citation Analysis]
|
| 121 |
Zhang C, Wang G, Zhou H, Lei G, Yang L, Fang Z, Shi S, Li J, Han Z, Song Y, Liu S. Preoperative platelet count, preoperative hemoglobin concentration and deep hypothermic circulatory arrest duration are risk factors for acute kidney injury after pulmonary endarterectomy: a retrospective cohort study. J Cardiothorac Surg 2019;14:220. [PMID: 31888760 DOI: 10.1186/s13019-019-1026-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 122 |
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol 2019;15:275-89. [PMID: 30792480 DOI: 10.1038/s41581-019-0119-6] [Cited by in Crossref: 327] [Cited by in F6Publishing: 344] [Article Influence: 81.8] [Reference Citation Analysis]
|
| 123 |
Nlandu Y, Pourcine F, Vong LVP, Chelly J, Jochmans S, Mazerand S, Monchi M. Cabazitaxel Induced Thrombotic Microangiopathy in a Patient with Prostate Cancer. Case Reports in Nephrology 2019;2019:1-3. [DOI: 10.1155/2019/8591283] [Reference Citation Analysis]
|
| 124 |
Bommer M, Wölfle-Guter M, Bohl S, Kuchenbauer F. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies. Dtsch Arztebl Int 2018;115:327-34. [PMID: 29875054 DOI: 10.3238/arztebl.2018.0327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 125 |
Yee Y, Angkodjojo S, Tan PH. Chronic thrombotic microangiopathy secondary to antiphospholipid syndrome, presenting with severe hypertension and chronic renal impairment. BMJ Case Rep 2019;12:e231434. [PMID: 31527221 DOI: 10.1136/bcr-2019-231434] [Reference Citation Analysis]
|
| 126 |
Noutsos T, Currie BJ, Isbister GK. Snakebite associated thrombotic microangiopathy: a protocol for the systematic review of clinical features, outcomes, and role of interventions. Syst Rev 2019;8:212. [PMID: 31439028 DOI: 10.1186/s13643-019-1133-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 127 |
Calvaruso L, Naticchia A, Ferraro PM, Vischini G, Costanzi S. Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report. Case Rep Nephrol 2019;2019:9264824. [PMID: 31360562 DOI: 10.1155/2019/9264824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 128 |
Mira FS, Nunes AL, Elvas AR, Oliveira N. Atypical haemolytic uremic syndrome from multiple missenses to a full-blown disease. BMJ Case Rep 2019;12:e230026. [PMID: 31253663 DOI: 10.1136/bcr-2019-230026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 129 |
Bouarich H, Fernández Rodríguez M, Blasco Martínez A. Microangiopatías trombóticas. Medicine - Programa de Formación Médica Continuada Acreditado 2019;12:4823-4830. [DOI: 10.1016/j.med.2019.06.012] [Reference Citation Analysis]
|
| 130 |
Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G. An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy. Clin Kidney J 2019;12:333-7. [PMID: 31198225 DOI: 10.1093/ckj/sfz040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 131 |
Ye W, Shu H, Wen Y, Ye W, Li H, Qin Y, Chen L, Li X. Renal histopathology of prolonged acute kidney injury in HELLP syndrome: a case series and literature review. Int Urol Nephrol 2019;51:987-94. [PMID: 30989562 DOI: 10.1007/s11255-019-02135-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 132 |
Honma F, Fujigaki Y, Nemoto Y, Kikuchi H, Nagura M, Arai S, Ishizawa K, Yamazaki O, Tamura Y, Kondo F, Ohashi R, Uchida S, Shibata S. A Case of Rheumatoid Arthritis Presenting with Renal Thrombotic Microangiopathy Probably due to a Combination of Chronic Tacrolimus Arteriolopathy and Severe Hypertension. Case Rep Nephrol 2019;2019:3923190. [PMID: 30963011 DOI: 10.1155/2019/3923190] [Reference Citation Analysis]
|
| 133 |
Filho JCCL, Ogawa MY, de Souza Andrade TH, de Andrade Cordeiro Gadelha S, Fernandes PFCBC, Queiroz AL, Daher EF. Spectrum of acute kidney injury associated with cocaine use: report of three cases. BMC Nephrol 2019;20:99. [PMID: 30894132 DOI: 10.1186/s12882-019-1279-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 134 |
Jacobs E, Ortiz C, Licht C. The Role of Complement in the Pathogenesis of HUS and the TMA Spectrum Disorders. Curr Pediatr Rep 2019;7:1-11. [DOI: 10.1007/s40124-019-00186-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 135 |
Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report. BMC Nephrol. 2019;20:14. [PMID: 30634936 DOI: 10.1186/s12882-018-1194-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 136 |
Person F, Zipfel PF, Wiech T. Thrombotische Mikroangiopathie: Was gibt es Neues? Nephrologe 2019;14:26-31. [DOI: 10.1007/s11560-018-0293-8] [Reference Citation Analysis]
|
| 137 |
Al-Naimi MS, Rasheed HA, Hussien NR, Al-Kuraishy HM, Al-Gareeb AI. Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury. J Adv Pharm Technol Res 2019;10:95-9. [PMID: 31334089 DOI: 10.4103/japtr.JAPTR_336_18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 138 |
Alidoost M, Haroon A, Gupta V, Asif A, Hossain MA. What the Internist Should Know about Thrombotic Microangiopathies. IJCM 2019;10:651-61. [DOI: 10.4236/ijcm.2019.1012054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 139 |
Feitz WJC, van de Kar NCAJ, Orth-Höller D, van den Heuvel LPJW, Licht C. The genetics of atypical hemolytic uremic syndrome. Med Genet 2018;30:400-9. [PMID: 30930551 DOI: 10.1007/s11825-018-0216-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 140 |
Feitz WJC, van de Kar NCAJ, Orth-Höller D, van den Heuvel LPJW, Licht C. The genetics of atypical hemolytic uremic syndrome. Med Genet 2018;30:400-9. [PMID: 30930551 DOI: 10.1007/s11825-018-0216-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 141 |
Gauckler P, Shin JI, Mayer G, Kronbichler A. Eosinophilia and Kidney Disease: More than Just an Incidental Finding? J Clin Med 2018;7:E529. [PMID: 30544782 DOI: 10.3390/jcm7120529] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 142 |
Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141 [PMID: 30211021 DOI: 10.5500/wjt.v8.i5.122] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 143 |
Wong EKS, Kavanagh D. Diseases of complement dysregulation-an overview. Semin Immunopathol 2018;40:49-64. [PMID: 29327071 DOI: 10.1007/s00281-017-0663-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
|
